CTLA4 and metastatic melanoma: When metastatic melanoma patients on CTLA-4 blockade and PD-1 blockade were ranked by the normalized expression of each of these genes, the sum of these ranks was an excellent predictor (area under ROC curve >0.95) of eventual response to CTLA-4 blockade and PD-1 blockade respectively (Figure 4).